EyePoint, Inc. EYPT
0.40 USD 0.00 (+0.00%)
At closeNov 4, 2026, 8:59 AM EST
0.40 0.00 +0.03%
Pre-market · Nov 4, 8:59 AM ET
Day range unavailable
0.34 52-week range 19.11
- YTD
- -97.81%
- 1 year
- -96.77%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 40.93 +10134.7% upside
Now 0.3999
- Target (low)
- 20.00
- Target (mean)
- 40.93
- Target (high)
- 68.00
Ratings (0m) 14 14 buy · 0 hold · 0 sell
- Strong buy3
- Buy11
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 14
- 2 months ago 12
- 3 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.921 | -1.15 – -0.60 | -0.85 | -8.4% | 245.93K | -74.5% | 12 |
| Next quarter | -0.86247 | -1.27 – -0.48 | -0.81 | -6.5% | 300.36K | -51.5% | 12 |
| Current year | -3.84 | -4.37 – -3.15 | -3.17 | -21.1% | 1.75M | -94.4% | 12 |
| Next year | -3.01 | -4.87 – -1.55 | -3.84 | +21.5% | 21.92M | +1149.0% | 12 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Aug 6, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Aug 6, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 16, 2026 | Stifel | Initiated | — | Buy |
| Jul 1, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Jun 24, 2026 | Guggenheim | Reiterated | Buy | Buy |
| May 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Mar 9, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 5, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 4, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Nov 6, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 7, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Aug 6, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 17, 2025 | RBC Capital | Initiated | — | Outperform |
| May 29, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 16, 2025 | Mizuho | Maintained | Outperform | Outperform |
| May 8, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Mar 6, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Mar 6, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 6, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Jan 7, 2025 | Citigroup | Initiated | — | Buy |
| Dec 5, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 11, 2024 | Baird | Maintained | Outperform | Outperform |
| Nov 11, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 8, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Oct 29, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Oct 25, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 13, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Jun 28, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Jun 27, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |